2m 2m 2m 2m 2m 2m 2m
Haemonetics (HAE)
NYSE
$108.99+$0.19 (+0.17%)
Price as of Aug 21, 2026 7:30 PM EDT- $5.0BMarket Cap
- 93.01%1-Year Change
- Medical DevicesIndustry
Haemonetics (HAE)
$108.99+$0.19 (+0.17%)
Earnings Score
Valuation | HAE | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | 1 | ||
Growth | 0 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | HAE | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 36.15% | ||
12-Month Momentum | 43.39% | ||
3-Month Risk Adjusted Momentum | 218.48% | ||
12-Month Risk Adjusted Momentum | 94.19% |
True Yield
Valuation | HAE | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | 0.56% | ||
Net Debt Paydown Yield | 1.66% |
Financial Health Score
Valuation | HAE | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 6 |